Research on complicated urinary tract infections
POS-cUTI:Perpetual Observational Study on Complicated Urinary Tract Infections
This study is trying to gather information on complicated urinary tract infections to better understand their causes and see if existing medications or new treatments can help people who suffer from them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 16000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | European Clinical Research Alliance for Infectious Diseases (ECRAID) Academic / other |
| Locations | 1 site (Sevilla) |
| Trial ID | NCT05458700 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on complicated urinary tract infections (cUTIs), which are a significant cause of morbidity and mortality. It aims to collect detailed information on microbial pathogens associated with UTIs, their clinical manifestations, and the impact of anatomical or functional abnormalities in the urinary tract. The study will utilize data from various European clinical research networks to enhance understanding and treatment approaches for cUTIs, including the potential repurposing of existing drugs and exploring non-antibiotic therapies.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals with documented microbial pathogens causing urinary tract infections, accompanied by specific clinical symptoms and underlying urinary tract abnormalities.
Not a fit: Patients without a documented microbial pathogen or those not exhibiting the required clinical symptoms may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for patients suffering from complicated urinary tract infections.
How similar studies have performed: Other studies have shown success in addressing complicated urinary tract infections through similar observational approaches, indicating potential for meaningful advancements.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * A documented microbial pathogen on culture of blood OR urine according to standards of interpretation regarding to the type of infection, pathogen, quantitative culture results and sample. Guide for adequate interpretation is detailed in Lab Manual. However, if the local laboratory uses diferent microbiological criteria, patients will be elegible and the criteria used will be collected AND * Local and systemic signs and symptoms of UTI including at least one of these two: (a) fever (i.e.,temperature greater than 38ºC), chills or malaise; and (b) flank pain, back pain, costo-vertebral angle pain or tenderness, dysuria or urinary urgency, AND * It occurs in the presence of a functional or anatomical abnormality of the urinary tract or in the presence of catheterization, including (but not limited to) presence of a urinary catheter; 100 mL or more of residual urine after voiding (neurogenic bladder); obstructive uropathy (nephrolithiasis, fibrosis); azotemia caused by intrinsic renal disease; urinary retention, including retention caused by benign prostatic hypertrophy. * Patients with pyelonephritis or bacteremia with a urinary tract source, regardless of underlying abnormalities of the urinary tract, are also to be included. * Patients with urinary catheter presenting with fever, bacteriuria and bacteraemia caused by the same urinary pathogen can be included if other sources of bacteraemia are reasonably discarded. * Depending on the country regulation: The patient, family or legally authorised representative signed the informed consent to participate or; notification of non-objection to the use of pseudo-anonymized personal and medical data. Exclusion Criteria: * Patients with a life expectancy previous to development of cUTI \<30 days and those exclusively under palliative care in whom any eventually needed invasive procedure would not be performed. * Patients who died in \<48 hours since the presentation with cUTI * Patients participating in RCT for treatment of cUTI * \>96 hours since from the clinical diagnosis of cUTI. I.e. \>96 hours from positive urine/blood culture.
Where this trial is running
Sevilla
- Hospital Universitario Virgen Macarena — Sevilla, Spain (Recruiting)
Study contacts
- Study coordinator: Elisa Moreno Mellado
- Email: elisamoreno500@hotmail.com
- Phone: 617245402
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.